Raushan T. Kurmasheva

Venetoclax responses of pediatric ALL xenografts reveal sensitivity of MLL-rearranged leukemia

Seong Lin Khaw, Santi Suryani, Kathryn Evans et al. · Blood · 2016 · 170 citations · Full text

Genomic Profiling of Childhood Tumor Patient-Derived Xenograft Models to Enable Rational Clinical Trial Design

Jo Lynne Rokita, Komal S. Rathi, Maria Cardenas et al. · Cell Reports · 2019 · 160 citations · Full text

The Insulin-like Growth Factor-1 Receptor–Targeting Antibody, CP-751,871, Suppresses Tumor-Derived VEGF and Synergizes with Rapamycin in Models of Childhood Sarcoma

Raushan T. Kurmasheva, Lorina Dudkin, Catherine A. Billups et al. · Cancer Research · 2009 · 149 citations · Full text

Initial testing (stage 1) of tazemetostat (EPZ‐6438), a novel EZH2 inhibitor, by the Pediatric Preclinical Testing Program

Raushan T. Kurmasheva, Melissa Sammons, Edward Favours et al. · Pediatric Blood & Cancer · 2016 · 118 citations · Full text

The B7-H3–Targeting Antibody–Drug Conjugate m276-SL-PBD Is Potently Effective Against Pediatric Cancer Preclinical Solid Tumor Models

Nathan M. Kendsersky, Jarrett M. Lindsay, E. Anders Kolb et al. · Clinical Cancer Research · 2021 · 117 citations · Full text